Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame
Primary	HbA1c change from baseline	13 weeks
Primary	Rate of severe hypoglycemia requiring assistance to actively administer treatment	13 weeks
Primary	Rate of severe hypoglycemia resulting in seizure/loss of consciousness	13 weeks
Primary	Rate of hyperosmolar hyperglycemic syndrome (HHS) or diabetic ketoacidosis (DKA)	13 weeks
Secondary	% time < 54 mg/dL	13 weeks
Other	Mean glucose	13 weeks
Other	% time 70-180 mg/dL	13 weeks
Other	% time > 180 mg/dL	13 weeks
Other	% time > 250 mg/dL	13 weeks
Other	Standard deviation of glucose	13 weeks
Other	% time < 70 mg/dL	13 weeks
Other	Coefficient of variation of glucose	13 weeks

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07911566/registered